| Globepharm Limited |
| Registered number: |
01823324 |
| Abbreviated Balance Sheet |
| as at 31 July 2014 |
|
| Notes |
|
|
2014 |
|
|
2013 |
| £ |
£ |
| Fixed assets |
| Intangible assets |
2 |
|
|
1 |
|
|
1 |
|
| Creditors: amounts falling due within one year |
|
|
(66,676) |
|
|
(66,676) |
|
| Net current liabilities |
|
|
|
(66,676) |
|
|
(66,676) |
|
| Net liabilities |
|
|
|
(66,675) |
|
|
(66,675) |
|
|
|
|
|
|
|
|
| Capital and reserves |
| Called up share capital |
3 |
|
|
100 |
|
|
100 |
| Profit and loss account |
|
|
|
(66,775) |
|
|
(66,775) |
|
| Shareholders' funds |
|
|
|
(66,675) |
|
|
(66,675) |
|
|
|
|
|
|
|
|
| The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 480 of the Companies Act 2006 relating to small companies. |
| Members have not required the company to obtain an audit in accordance with section 476 of the Act. |
| The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. |
| The accounts have been prepared in accordance with the provisions in Part 15 of the Companies Act 2006 applicable to companies subject to the small companies regime. |
|
|
|
| J N Bleby |
| Director |
| Approved by the board on 13 March 2015 |
|
